Biodyl

Last updated

Biodyl is a trademark of Merial for a dietary supplement used in animals. It is manufactured in two formulations: a powder for use in an individual animal's drinking water, and an injectable solution. The injectable solution is available by veterinary prescription in some countries and over the counter in others.

Contents

Physical and chemical properties

Biodyl is formulated as a powder to be given in water, and as an injectable solution. The injectable solution is given under the skin, in the muscle, or in a vein, depending on the species of animal. [1] Its intended uses include reducing physiological stress such as due to being transported, and preventing azoturia in performance animals. The manufacturer's own product information describes Biodyl as an "injection solution containing metabolic constituents (adenosine triphosphoric acid or ATP, magnesium and potassium aspartate, sodium selenite and vitamin B 12) for debility, convalescence and myopathies." [2]

Composition: [1] [3]

In the United States, Biodyl is not FDA approved, "in that there is not in effect an approval of an application filed with respect to its intended use or uses". [4]

Adverse effects

The manufacturer however, states that "Biodyl is safe when used as directed. It has been around from the 1950s and adverse reactions have been exceedingly rare over many years of tracking. Less than one animal in over 2 million doses." [5]

Veterinary use

Implication in polo pony deaths

In April 2009, the sudden deaths of 21 polo ponies at Palm Beach International Polo Club in Florida were attributed by a polo team captain to error or tampering in the team's supply of Biodyl. [6] [7] A newspaper in Argentina reported 3 similar deaths of horses at an international competition in Uruguay. [6]

In the United States, concerns about a possible manufacturing error or tampering were lost amid a media outcry about the "illegal" use of "illegal" drugs not approved by the FDA, even "banned" by the FDA. [8] In the US, Biodyl is neither an illegal drug nor a banned drug, but it is an unapproved drug. Although Biodyl is a dietary supplement, a type of product that normally is not subject to FDA approval, FDA approval is required to market injectable solutions (except animal vaccines, which are subject to USDA approval). An Associated Press story misreported an October 2008 FDA refusal to permit commercial importation of the solution as a refusal to approve the solution. In fact, Biodyl is not FDA-approved because the manufacturer has never submitted an application for FDA approval. [9] Also, the FDA may permit the importation of unapproved drugs for personal use for pets. [10]

However, on April 23 a new concern emerged when a reputable pharmacy in Ocala, Florida disclosed that in compounding a preparation for the polo ponies which may have been intended to substitute for Biodyl, the pharmacy accidentally used an incorrect quantity of one of the ingredients. [11] Compounding of drugs for use in animals is a subject of concern for the FDA. [12]

See also

Related Research Articles

<span class="mw-page-title-main">Food and Drug Administration</span> United States federal agency

The United States Food and Drug Administration is a federal agency of the Department of Health and Human Services. The FDA is responsible for protecting and promoting public health through the control and supervision of food safety, tobacco products, caffeine products, dietary supplements, prescription and over-the-counter pharmaceutical drugs (medications), vaccines, biopharmaceuticals, blood transfusions, medical devices, electromagnetic radiation emitting devices (ERED), cosmetics, animal foods & feed and veterinary products.

An epinephrine autoinjector is a medical device for injecting a measured dose or doses of epinephrine (adrenaline) by means of autoinjector technology. It is most often used for the treatment of anaphylaxis. The first epinephrine autoinjector was brought to market in 1983.

<span class="mw-page-title-main">Prescription drug</span> Medication legally requiring a medical prescription before it can be dispensed

A prescription drug is a pharmaceutical drug that is permitted to be dispensed only to those with a medical prescription. In contrast, over-the-counter drugs can be obtained without a prescription. The reason for this difference in substance control is the potential scope of misuse, from drug abuse to practicing medicine without a license and without sufficient education. Different jurisdictions have different definitions of what constitutes a prescription drug.

<span class="mw-page-title-main">Nootropic</span> Compound intended to improve cognitive function

Nootropics, colloquially brain supplements, smart drugs and cognitive enhancers, are natural, semisynthetic or synthetic compounds which purportedly improve cognitive functions, such as executive functions, attention or memory.

<span class="mw-page-title-main">Stanozolol</span> Discontinued steroid for heart treatment

Stanozolol, sold under many brand names, is a synthetic androgen and anabolic steroid (AAS) medication derived from dihydrotestosterone (DHT). It is used to treat hereditary angioedema. It was developed by American pharmaceutical company Winthrop Laboratories in 1962, and has been approved by the U.S. Food and Drug Administration for human use, though it is no longer marketed in the USA. It is also used in veterinary medicine. Stanozolol has mostly been discontinued, and remains available in only a few countries. It is given by mouth in humans or by injection into muscle in animals.

<span class="mw-page-title-main">Guaifenesin</span> Expectorant medication

Guaifenesin, also known as glyceryl guaiacolate, is an expectorant medication taken by mouth and marketed as an aid to eliminate sputum from the respiratory tract. Chemically, it is an ether of guaiacol and glycerine. It may be used in combination with other medications. A 2014 study found that guaifenesin has no effect on sputum production or clearance in upper respiratory infections.

<span class="mw-page-title-main">Adrafinil</span> Wakefulness-promoting drug

Adrafinil, sold under the brand name Olmifon, is a wakefulness-promoting medication that was formerly used in France to improve alertness, attention, wakefulness, and mood, particularly in the elderly. It was also used off-label by individuals who wished to avoid fatigue, such as night workers or others who needed to stay awake and alert for long periods of time. Additionally, the medication has been used non-medically as a novel vigilance-promoting agent.

Bioidentical hormone replacement therapy (BHRT), also known as bioidentical hormone therapy (BHT) or natural hormone therapy, is the use of hormones that are identical on a molecular level with endogenous hormones in hormone replacement therapy. It may also be combined with blood and saliva testing of hormone levels, and the use of pharmacy compounding to obtain hormones in an effort to reach a targeted level of hormones in the body. A number of claims by some proponents of BHT have not been confirmed through scientific testing. Specific hormones used in BHT include estrone, estradiol, progesterone, testosterone, dehydroepiandrosterone (DHEA), and estriol.

<span class="mw-page-title-main">Investigational New Drug</span> USFDA program and prodecures

The United States Food and Drug Administration's Investigational New Drug (IND) program is the means by which a pharmaceutical company obtains permission to start human clinical trials and to ship an experimental drug across state lines before a marketing application for the drug has been approved. Regulations are primarily at 21 CFR 312. Similar procedures are followed in the European Union, Japan, and Canada.

Off-label use is the use of pharmaceutical drugs for an unapproved indication or in an unapproved age group, dosage, or route of administration. Both prescription drugs and over-the-counter drugs (OTCs) can be used in off-label ways, although most studies of off-label use focus on prescription drugs.

<span class="mw-page-title-main">Adaptogen</span> Substance used in herbal medicine

Adaptogens or adaptogenic substances are used in herbal medicine for the purported stabilization of physiological processes and promotion of homeostasis.

<span class="mw-page-title-main">Sodium selenite</span> Chemical compound

Sodium selenite is the inorganic compound with the formula Na2SeO3. This salt is a colourless solid. The pentahydrate Na2SeO3(H2O)5 is the most common water-soluble selenium compound.

<span class="mw-page-title-main">Compounding</span> Preparation of a custom medication

In the field of pharmacy, compounding is preparation of custom medications to fit unique needs of patients that cannot be met with mass-produced products. This may be done, for example, to provide medication in a form easier for a given patient to ingest, or to avoid a non-active ingredient a patient is allergic to, or to provide an exact dose that isn't otherwise available. This kind of patient-specific compounding, according to a prescriber's specifications, is referred to as "traditional" compounding. The nature of patient need for such customization can range from absolute necessity to individual optimality to even preference.

<span class="mw-page-title-main">Sodium selenate</span> Chemical compound

Sodium selenate is the inorganic compound with the formula Na
2SeO
4, not to be confused with sodium selenite. It exists as the anhydrous salt, the heptahydrate, and the decahydrate. These are white, water-soluble solids. The decahydrate is a common ingredient in multivitamins and livestock feed as a source of selenium. The anhydrous salt is used in the production of some glass. Although the selenates are much more toxic, many physical properties of sodium selenate and sodium sulfate are similar.

B&O Supprettes is the brand name for a prescription medication containing powdered opium and belladonna alkaloids in a suppository form. They are indicated for the treatment of moderate to severe pain from urethral spasm, and for extending the interval(s) between injections of opiates. The drug has various "off label" uses, including renal colic, intestinal cramps, tenesmus and diarrhea. They are also often prescribed after urinary bladder surgery. B&O Supprettes was unique in the United States because they were the only drug containing opium that is for suppository use sold in the US and, in fact, one of the very few medications that contains opium in any form in the US along with paregoric and opium tincture (laudanum).

An Emergency Use Authorization (EUA) in the United States is an authorization granted to the Food and Drug Administration (FDA) under sections of the Federal Food, Drug, and Cosmetic Act as added to and amended by various Acts of Congress, including by the Pandemic and All-Hazards Preparedness Reauthorization Act of 2013 (PAHPRA), as codified by 21 U.S.C. § 360bbb-3, to allow the use of a drug prior to approval. It does not constitute approval of the drug in the full statutory meaning of the term, but instead authorizes the FDA to facilitate availability of an unapproved product, or an unapproved use of an approved product, during a declared state of emergency from one of several agencies or of a "material threat" by the Secretary of Homeland Security.

<span class="mw-page-title-main">McGuff Companies</span>

The McGuff Companies consist of three entities: a wholesale distributor of medical supplies, a compounding pharmacy, and a pharmaceutical manufacturing facility which produces sterile injectables for national and international distribution. The McGuff Companies have been featured in the International Journal of Pharmaceutical Compounding (IJPC).

<span class="mw-page-title-main">New England Compounding Center meningitis outbreak</span> Fungal meningitis outbreak in the United States

A New England Compounding Center meningitis outbreak that began in September 2012 sickened 798 individuals and resulted in the deaths of more than 100 people. In September 2012, the Centers for Disease Control and Prevention, in collaboration with state and local health departments and the Food and Drug Administration (FDA), began investigating a multistate outbreak of fungal meningitis and other infections among patients who had received contaminated steroid injections from the New England Compounding Center (NECC) in Framingham, Massachusetts. The NECC was classified as a compounding pharmacy. The traditional role of compounding pharmacies is to make drugs prescribed by doctors for specific patients with needs that can't be met by commercially available drugs.

<span class="mw-page-title-main">Dietary Supplement Health and Education Act of 1994</span> 1994 statute of United States Federal legislation

The Dietary Supplement Health and Education Act of 1994 ("DSHEA"), is a 1994 statute of United States Federal legislation which defines and regulates dietary supplements. Under the act, supplements are regulated by the FDA for Good Manufacturing Practices under 21 CFR Part 111. The act was intended to exempt the dietary and herbal supplement industry from most FDA drug regulations, allowing them to be sold and marketed without scientific backing for their health and medical claims.

<span class="mw-page-title-main">3-Nitrooxypropanol</span> Chemical compound

3-Nitrooxypropanol, abbreviated 3-NOP or 3NOP, is an organic compound with the formula HOCH2CH2CH2ONO2. It is the mononitrate ester of 1,3-propanediol. The compound is an inhibitor of the enzyme methyl coenzyme M reductase (MCR). MCR catalyzes the final step in methanogenesis. When it is fed to ruminants, their methane production is diminished.

References

  1. 1 2 "BIODYL" (PDF). M.C.I. Santé Animale. Archived from the original (PDF) on 2010-06-02. Retrieved 2009-04-22.
  2. ↑ "Swine: Product Information". Merial. Archived from the original on August 28, 2008. Retrieved April 22, 2009.
  3. ↑ "Biodyl". Archived from the original on 2009-04-30.
  4. ↑ "Refusal Details as Recorded in OASIS by FDA for Refusal 112-4397009-5/1/1/". Food and Drug Administration. Retrieved 2009-06-14.
  5. ↑ Johnson, Craig (April 22, 2009). "Scrutiny in horse deaths falls on vitamins". CNN. Retrieved April 22, 2009.
  6. 1 2 "Una historia que aún no despejó las dudas: Avanzan las investigaciones por la muerte de los equinos: en las próximas horas habría resultados" (in Spanish). La Nacion Deportiva. April 22, 2009. Retrieved April 22, 2009.
  7. ↑ Brian Haas, Missy Diaz (April 22, 2009). "Polo team captain: Vitamin likely killed 21 horses". South Florida Sun-Sentinel. Archived from the original on April 21, 2009. Retrieved April 22, 2009.
  8. ↑ "Banned Vitamin Supplement May Have Caused Horse Deaths Polo Team Member Tells Newspaper Horses Received French-Made Drug". West Palm Beach News. April 22, 2009. Archived from the original on July 18, 2011. Retrieved April 24, 2009.
  9. ↑ "Correction: Dead polo horses story". Associated Press via Google. April 23, 2009. Retrieved April 24, 2009.[ dead link ] "In an April 22 story about 21 polo horses that died in Florida, The Associated Press reported erroneously that the Food and Drug Administration had refused to approve the French-made supplement Biodyl for use in the U.S. The manufacturer has never submitted the supplement for approval."
  10. ↑ "CVM and Compliance". U.S. FDA Center for Veterinary Medicine. March 26, 2008. Archived from the original on January 15, 2008. Retrieved April 24, 2009.
  11. ↑ Bill DiPaolo, Jane Musgrave (April 23, 2009). "Pharmacy: We made mistake on supplement given to dead polo ponies". The Miami Herald. Retrieved April 23, 2009.[ dead link ]
  12. ↑ "Sec. 608.400 - Compounding of Drugs for Use in Animals (CPG 7125.40)". Compliance Policy Guidance. U.S. Food and Drug Administration. July 8, 2003. Archived from the original on January 15, 2008. Retrieved April 24, 2009.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.